| Christel M Zeumer, MD | |
|
2801 Atlantic Ave, Long Beach, CA 90806-1737 | |
| (562) 933-2000 | |
| (818) 587-2493 |
| Full Name | Christel M Zeumer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 2801 Atlantic Ave, Long Beach, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497701148 | NPI | - | NPPES |
| 00G784750 | Other | CA | BLUE SHIELD |
| 00G784750 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G78475 (California) | Primary |
| Entity Name | Columbia Emergency Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871551119 PECOS PAC ID: 2668376500 Enrollment ID: O20031121000897 |
News Archive
Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.
Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR (fidaxomicin) tablets for the treatment of adults suffering with a Clostridium difficile infection (CDI), also known as C. difficile-associated diarrhea.
"While the long term effects of genome mutations are quite well understood, we did not know how often new mutations arise in the first place," said Detlef Weigel, director at the Max Planck Institute in Germany. It is routine today to compare the genomes of related animal or plant species.
For-Profit Hospital Status And Rehospitalizations At Different Hospitals: An Analysis of Medicare Data - "Rehospitalization within the first 30 days of discharge affects 1 in 5 hospitalized Medicare fee-for-service patients and costs approximately $17.4 billion in payments annually ... the top 4 factors most related to the risk for rehospitalization at a different facility were initial admission to a for-profit index hospital … lower-volume index hospital (hospitals with <1000 annual discharges) … hospital with a major medical school affiliation … and being disabled."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christel M Zeumer, MD Po Box 1490, Long Beach, CA 90801-1490 Ph: (888) 237-1803 | Christel M Zeumer, MD 2801 Atlantic Ave, Long Beach, CA 90806-1737 Ph: (562) 933-2000 |
News Archive
Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.
Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR (fidaxomicin) tablets for the treatment of adults suffering with a Clostridium difficile infection (CDI), also known as C. difficile-associated diarrhea.
"While the long term effects of genome mutations are quite well understood, we did not know how often new mutations arise in the first place," said Detlef Weigel, director at the Max Planck Institute in Germany. It is routine today to compare the genomes of related animal or plant species.
For-Profit Hospital Status And Rehospitalizations At Different Hospitals: An Analysis of Medicare Data - "Rehospitalization within the first 30 days of discharge affects 1 in 5 hospitalized Medicare fee-for-service patients and costs approximately $17.4 billion in payments annually ... the top 4 factors most related to the risk for rehospitalization at a different facility were initial admission to a for-profit index hospital … lower-volume index hospital (hospitals with <1000 annual discharges) … hospital with a major medical school affiliation … and being disabled."
› Verified 8 days ago
Gregory W Bush, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2801 Atlantic Ave, Long Beach, CA 90806 Phone: 562-933-2000 Fax: 818-587-2493 | |
Dr. Neel Amar Shah, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 Linden Ave, Long Beach, CA 90813 Phone: 562-491-9761 Fax: 562-491-9264 | |
Dr. Andrew Wittenberg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2801 Atlantic Ave, Long Beach, CA 90806 Phone: 562-933-2000 | |
Dr. Lauren Valerie Sylwanowicz, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 Linden Ave, Long Beach, CA 90813 Phone: 562-491-9000 | |
Eber Sanchez Zelaya, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 6510 Falcon Ave, Long Beach, CA 90805 Phone: 562-506-8631 | |
Dr. George Robert Knull, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1936 E Anaheim St, Long Beach, CA 90813 Phone: 714-309-4688 | |
Dr. Hoskote B. Venkatesh, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5901 East 7th Street, Long Beach, CA 90822 Phone: 562-826-8000 Fax: 562-826-8159 |